Canada Pension Plan Investment Board’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,700
Closed -$295K – 1789
2026
Q1
$295K Sell
2,700
-3,800
-58% -$362K ﹤0.01% 1426
2025
Q4
$527K Sell
6,500
-1,400
-18% -$121K ﹤0.01% 1287
2025
Q3
$691K Buy
7,900
+1,600
+25% +$143K ﹤0.01% 1021
2025
Q2
$523K Buy
6,300
+5,000
+385% +$418K ﹤0.01% 1017
2025
Q1
$109K Sell
1,300
-400
-24% -$37.2K ﹤0.01% 1126
2024
Q4
$157K Buy
1,700
+900
+113% +$86.5K ﹤0.01% 1207
2024
Q3
$74.3K Sell
800
-200
-20% -$17.3K ﹤0.01% 1204
2024
Q2
$82.3K Buy
+1,000
New +$73.5K ﹤0.01% 1218

Other funds holding LMAT

Canada Pension Plan Investment Board's LMAT Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 2,700 shares — an estimated $295K sold.

Canada Pension Plan Investment Board first reported a position in LMAT in Q2 2024 and held it in 8 quarters. The position peaked at $691K in Q3 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 2,700 LeMaitre Vascular shares in Q2 2026, an estimated $295K.
  • Canada Pension Plan Investment Board first reported a position in LeMaitre Vascular in Q2 2024 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's LeMaitre Vascular position peaked at $691K in Q3 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.